Log in to save to my catalogue

CCR2-overexpressing mesenchymal stem cells targeting damaged liver enhance recovery of acute liver f...

CCR2-overexpressing mesenchymal stem cells targeting damaged liver enhance recovery of acute liver f...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3d58e05f9ce84a64ad295758b32e9fae

CCR2-overexpressing mesenchymal stem cells targeting damaged liver enhance recovery of acute liver failure

About this item

Full title

CCR2-overexpressing mesenchymal stem cells targeting damaged liver enhance recovery of acute liver failure

Publisher

England: BioMed Central Ltd

Journal title

Stem cell research & therapy, 2022-02, Vol.13 (1), p.55-55, Article 55

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Mesenchymal stem cell (MSC) transplantation is emerging as a promising cell therapeutic strategy in acute liver failure (ALF) clinical research. The potency of MSCs to migrate and engraft into targeted lesions could largely determine their clinical efficacy, in which chemokine/receptor axes play a crucial role. Unfortunately, the downregulation of...

Alternative Titles

Full title

CCR2-overexpressing mesenchymal stem cells targeting damaged liver enhance recovery of acute liver failure

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_3d58e05f9ce84a64ad295758b32e9fae

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3d58e05f9ce84a64ad295758b32e9fae

Other Identifiers

ISSN

1757-6512

E-ISSN

1757-6512

DOI

10.1186/s13287-022-02729-y

How to access this item